Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 8 | 2022 | 622 | 2.200 |
Why?
|
| Alcoholism | 5 | 2023 | 717 | 1.540 |
Why?
|
| Critical Illness | 5 | 2023 | 645 | 1.450 |
Why?
|
| Occupational Therapy | 2 | 2022 | 73 | 1.180 |
Why?
|
| Pneumonia | 4 | 2023 | 576 | 1.070 |
Why?
|
| Early Ambulation | 2 | 2017 | 14 | 1.050 |
Why?
|
| Physical Therapy Modalities | 3 | 2017 | 269 | 0.890 |
Why?
|
| Respiration, Artificial | 3 | 2017 | 526 | 0.840 |
Why?
|
| Mobility Limitation | 2 | 2019 | 60 | 0.770 |
Why?
|
| Psychomotor Agitation | 1 | 2020 | 66 | 0.700 |
Why?
|
| Aftercare | 2 | 2023 | 187 | 0.650 |
Why?
|
| Opioid-Related Disorders | 2 | 2023 | 422 | 0.630 |
Why?
|
| Cocaine-Related Disorders | 1 | 2019 | 107 | 0.600 |
Why?
|
| Betacoronavirus | 1 | 2020 | 254 | 0.570 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 234 | 0.560 |
Why?
|
| Fluid Therapy | 1 | 2017 | 122 | 0.550 |
Why?
|
| Marijuana Use | 1 | 2019 | 168 | 0.530 |
Why?
|
| Life Support Care | 1 | 2016 | 28 | 0.520 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2023 | 243 | 0.520 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2016 | 79 | 0.510 |
Why?
|
| HIV Infections | 3 | 2019 | 2473 | 0.500 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 344 | 0.500 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 336 | 0.490 |
Why?
|
| Neuromuscular Diseases | 1 | 2016 | 90 | 0.480 |
Why?
|
| Patient Discharge | 2 | 2023 | 770 | 0.480 |
Why?
|
| Hospitals, Teaching | 1 | 2015 | 103 | 0.480 |
Why?
|
| Alcohol Drinking | 2 | 2019 | 650 | 0.470 |
Why?
|
| Activities of Daily Living | 3 | 2023 | 352 | 0.450 |
Why?
|
| Clinical Protocols | 1 | 2015 | 233 | 0.450 |
Why?
|
| Hospitalization | 7 | 2023 | 1765 | 0.390 |
Why?
|
| Humans | 36 | 2023 | 115611 | 0.350 |
Why?
|
| Motor Activity | 1 | 2015 | 633 | 0.350 |
Why?
|
| Middle Aged | 13 | 2023 | 27014 | 0.340 |
Why?
|
| Adult | 15 | 2023 | 30726 | 0.340 |
Why?
|
| Retrospective Studies | 12 | 2023 | 12608 | 0.340 |
Why?
|
| Referral and Consultation | 1 | 2014 | 646 | 0.330 |
Why?
|
| Length of Stay | 3 | 2020 | 958 | 0.330 |
Why?
|
| Weight Gain | 1 | 2011 | 453 | 0.300 |
Why?
|
| Ethanol | 2 | 2022 | 549 | 0.290 |
Why?
|
| Cohort Studies | 7 | 2023 | 4945 | 0.290 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 990 | 0.290 |
Why?
|
| Female | 18 | 2023 | 59931 | 0.280 |
Why?
|
| Prospective Studies | 7 | 2023 | 6264 | 0.260 |
Why?
|
| Respiratory Insufficiency | 2 | 2023 | 292 | 0.250 |
Why?
|
| Male | 16 | 2023 | 55967 | 0.250 |
Why?
|
| Washington | 2 | 2015 | 134 | 0.230 |
Why?
|
| Prevalence | 4 | 2019 | 2265 | 0.230 |
Why?
|
| Body Mass Index | 1 | 2011 | 1971 | 0.220 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 1440 | 0.220 |
Why?
|
| Quality of Life | 4 | 2023 | 2387 | 0.210 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 4438 | 0.200 |
Why?
|
| Telerehabilitation | 1 | 2022 | 26 | 0.200 |
Why?
|
| Aged | 6 | 2020 | 19255 | 0.190 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 2578 | 0.190 |
Why?
|
| Naltrexone | 1 | 2022 | 83 | 0.190 |
Why?
|
| Central Nervous System Depressants | 1 | 2021 | 82 | 0.190 |
Why?
|
| Exercise | 1 | 2011 | 1609 | 0.190 |
Why?
|
| Nursing Assessment | 1 | 2020 | 50 | 0.180 |
Why?
|
| Risk Factors | 3 | 2020 | 8699 | 0.180 |
Why?
|
| Mobile Applications | 1 | 2022 | 140 | 0.180 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2022 | 222 | 0.170 |
Why?
|
| Critical Care | 2 | 2021 | 477 | 0.170 |
Why?
|
| Frailty | 1 | 2022 | 116 | 0.170 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2021 | 160 | 0.170 |
Why?
|
| United States | 4 | 2022 | 12297 | 0.160 |
Why?
|
| Tobacco Smoking | 1 | 2018 | 21 | 0.160 |
Why?
|
| Pandemics | 3 | 2023 | 1334 | 0.160 |
Why?
|
| Inpatients | 1 | 2022 | 380 | 0.150 |
Why?
|
| Tobacco Use | 1 | 2018 | 59 | 0.150 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2019 | 99 | 0.150 |
Why?
|
| Tobacco Products | 1 | 2018 | 105 | 0.150 |
Why?
|
| Community-Acquired Infections | 1 | 2019 | 141 | 0.150 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2019 | 608 | 0.140 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 95 | 0.140 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2019 | 257 | 0.140 |
Why?
|
| Markov Chains | 1 | 2017 | 114 | 0.140 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2019 | 207 | 0.140 |
Why?
|
| Louisiana | 1 | 2016 | 24 | 0.140 |
Why?
|
| Linear Models | 1 | 2019 | 776 | 0.140 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 646 | 0.130 |
Why?
|
| Muscular Diseases | 1 | 2017 | 104 | 0.130 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 36 | 0.130 |
Why?
|
| Cognition | 1 | 2023 | 981 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2021 | 588 | 0.130 |
Why?
|
| Alcohol-Related Disorders | 1 | 2017 | 110 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 844 | 0.130 |
Why?
|
| Health Facility Size | 1 | 2015 | 12 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 759 | 0.120 |
Why?
|
| Homosexuality, Male | 1 | 2016 | 170 | 0.120 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 22 | 0.120 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 39 | 0.120 |
Why?
|
| Comorbidity | 1 | 2019 | 1473 | 0.120 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2019 | 337 | 0.120 |
Why?
|
| Physical Therapists | 1 | 2014 | 38 | 0.110 |
Why?
|
| Telemedicine | 1 | 2022 | 667 | 0.110 |
Why?
|
| Sex Factors | 1 | 2019 | 1737 | 0.110 |
Why?
|
| Logistic Models | 2 | 2017 | 1856 | 0.110 |
Why?
|
| Conscious Sedation | 1 | 2014 | 79 | 0.110 |
Why?
|
| Tracheostomy | 1 | 2014 | 100 | 0.110 |
Why?
|
| Colorado | 1 | 2022 | 4116 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 2 | 2023 | 249 | 0.100 |
Why?
|
| Nurses | 1 | 2014 | 151 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2018 | 805 | 0.100 |
Why?
|
| Data Collection | 1 | 2014 | 636 | 0.100 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 951 | 0.090 |
Why?
|
| Survivors | 2 | 2022 | 404 | 0.080 |
Why?
|
| Energy Intake | 1 | 2011 | 414 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1829 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 1447 | 0.070 |
Why?
|
| Time Factors | 1 | 2017 | 6165 | 0.070 |
Why?
|
| Physicians | 1 | 2014 | 776 | 0.070 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 89 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 4668 | 0.050 |
Why?
|
| Fatigue | 1 | 2023 | 296 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2021 | 318 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2022 | 741 | 0.040 |
Why?
|
| Adolescent | 3 | 2023 | 17903 | 0.040 |
Why?
|
| New Orleans | 1 | 2018 | 14 | 0.040 |
Why?
|
| Machine Learning | 1 | 2022 | 321 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2023 | 779 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2022 | 677 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2022 | 479 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2019 | 117 | 0.040 |
Why?
|
| Age Distribution | 1 | 2018 | 341 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2018 | 337 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 1377 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2021 | 684 | 0.040 |
Why?
|
| Tidal Volume | 1 | 2017 | 74 | 0.040 |
Why?
|
| Sputum | 1 | 2019 | 290 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 1137 | 0.040 |
Why?
|
| Anxiety | 1 | 2023 | 854 | 0.030 |
Why?
|
| Mental Health | 1 | 2022 | 571 | 0.030 |
Why?
|
| Selectins | 1 | 2016 | 7 | 0.030 |
Why?
|
| Angiopoietin-1 | 1 | 2016 | 10 | 0.030 |
Why?
|
| Angiopoietin-2 | 1 | 2016 | 12 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 2418 | 0.030 |
Why?
|
| Urban Population | 1 | 2018 | 406 | 0.030 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2016 | 89 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2021 | 958 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 2499 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1990 | 65 | 0.020 |
Why?
|
| Neurofibromatosis 1 | 1 | 1990 | 36 | 0.020 |
Why?
|
| Lung | 1 | 2022 | 3673 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1990 | 325 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 10487 | 0.010 |
Why?
|
| DNA | 1 | 1990 | 1356 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 32102 | 0.010 |
Why?
|
| Genetic Carrier Screening | 1 | 1990 | 24 | 0.010 |
Why?
|
| Lod Score | 1 | 1990 | 65 | 0.010 |
Why?
|
| DNA Probes | 1 | 1990 | 59 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1990 | 297 | 0.010 |
Why?
|
| Pedigree | 1 | 1990 | 467 | 0.010 |
Why?
|
| Alleles | 1 | 1990 | 794 | 0.000 |
Why?
|